With regard to malaria, malaria medication and the Department of National Defence, Veterans Affairs Canada, Health Canada, or the Privy Council Office, since November 4, 2015: (a) what are the details of all meetings involving the Department of National Defence, Veterans Affairs Canada, Health Canada, or the Privy Council Office where malaria, any malaria prevention treatments, Mefloquine, or Lariam was on the agenda, including the (i) date, (ii) attendees, (iii) description of meeting, (iv) contents of agenda or meeting notes, (v) location, (vi) decisions made; (b) what are the details of all briefing notes related to malaria, any malaria treatments, Mefloquine, or Lariam including the (i) date, (ii) title, (iii) summary, (iv) sender, (v) recipients, (vi) file number; (c) what is the current Department of National Defence policy regarding the distribution of Mefloquine and other malaria prevention treatments to members of the Canadian Forces; and (d) when did the policy come into effect?
In the House of Commons on March 20th, 2017. See this statement in context.